• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding
    logo
    Indoco Remedies Ltd.
    26 Aug 2025
    273.55
    0.16%
    Nirmal Bang Remains Structurally Positive On Indoco Remedies; Maintains 'Hold' Rating Check Target Price
    Nirmal Bang Remains Structurally Positive On Indoco Remedies; Maintains 'Hold' Rating Check Target Price
    NDTV Profit
    Nirmal Bang values the company at 11x Jul-27E EV/Ebitda and maintain Hold rating on Indoco Remedies, resulting in a target price of Rs 310.
    Copy LinkShare onShare on Share on Share on
    Indoco Remedies Ltd. has lost -26.98% in the last 1 Year
    logo
    Sun Pharmaceutical Industries Ltd.
    26 Aug 2025
    1593.60
    0.71%
    Sun Pharma shares slip 3% after BofA downgrade on premium valuations
    Sun Pharma shares slip 3% after BofA downgrade on premium valuations
    Economic Times
    Bank of America downgraded Sun Pharma stock to underperform' from neutral', citing risks to premium valuations and slower speciality execution. The brokerage cut its target price, flagging concerns over Ilumya's Medicare exposure, pricing pressures, and limited earnings visibility despite strong initial performance.
    Copy LinkShare onShare on Share on Share on
    Sun Pharmaceutical I.. has an average target of 2050.25 from 8 brokers.
    logo
    Senores Pharmaceuticals Ltd.
    25 Aug 2025
    719.15
    2.14%
    Broker's call: Senores Pharma (Buy)
    Business Line
    Choice International
    Copy LinkShare onShare on Share on Share on
    Senores Pharmaceuticals Ltd. has gained 39.53% in the last 3 Months
    logo
    Akums Drugs & Pharmaceuticals Ltd.
    25 Aug 2025
    460.20
    -1.17%
    Akums Drugs announces JV to set up manufacturing facility in Zambia
    Business Standard
    Akums will hold 51% in its joint venture with the Zambian government to set up a pharma manufacturing facility, marking its first overseas plant and Africa expansion
    Copy LinkShare onShare on Share on Share on
    Akums Drugs & Pharma.. has an average target of 655.00 from 1 broker.
    logo
    Sai Life Science Ltd.
    25 Aug 2025
    860.25
    1.38%
    Cohance Lifesciences and other pharma stocks jump up to 5% after Jefferies initiates Buy recommendation
    Cohance Lifesciences and other pharma stocks jump up to 5% after Jefferies initiates Buy recommendation
    Economic Times
    Cohance Lifesciences, Divi's Laboratories, and SAI Life Sciences rallied after Jefferies initiated coverage with Buy' ratings, citing strong growth prospects in India's CRDMO sector. The brokerage sees a high-teen revenue CAGR, led by China+1 diversification, pipeline visibility, and demand for diabetes and weight-loss therapies.
    Copy LinkShare onShare on Share on Share on
    Sai Life Science Ltd. has gained 56.69% in the last 1 Year
    logo
    Cipla Ltd.
    22 Aug 2025
    1553.40
    -1.55%
    Five Stocks To Buy Today: Devyani, Cipla, IndusInd Bank And OthersCheck Target Price
    Five Stocks To Buy Today: Devyani, Cipla, IndusInd Bank And OthersCheck Target Price
    NDTV Profit
    The stock recommendations come with specific target price and stop loss price.
    Copy LinkShare onShare on Share on Share on
    Cipla Ltd. has an average target of 1717.33 from 9 brokers.
    logo
    Cipla Ltd.
    22 Aug 2025
    1553.40
    -1.55%
    Looking for short-term F&O trade? Check this 'Bull Spread' on Cipla
    Business Standard
    Short term trend is positive as it is placed above its 5, 11 and 20 day EMA Stock price has broken out on the weekly chart with higher volumes
    Copy LinkShare onShare on Share on Share on
    Cipla Ltd. has an average target of 1717.33 from 9 brokers.
    logo
    Caplin Point Laboratories Ltd.
    22 Aug 2025
    USFDA Approval
    2138.40
    1.01%
    Stock Market Live Updates 22 August 2025: Stock to buy today: Caplin Point Laboratories
    Business Line
    Sensex, Nifty, Share Prices LIVE: The short-term outlook is bullish for Caplin Point Laboratories. The 4 per cent rise has taken the share price well above the 2,130-2,140 resistance zone. This region will now act as a good support and limit the downside. Below this 2,080 will be the next important support. Immediate resistance is at 2,230 which can be broken in the next few days. Such a break can take Caplin Point Laboratories share price up to 2,330 in the coming weeks. Traders can buy Caplin Point Laboratories now at 2,205. Accumulate on dips at 2,160. Keep the stop-loss at 2,110 initially. Trail the stop-loss up to 2,225 as soon as the stock goes up to 2,255. Move the stop-loss further up to 2,260 and 2,285 when the price touches 2,280 and 2,300 respectively. Exit the long positions at 2,320.
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors increased from 177 to 198 in Jun 2025 qtr.
    Stock to buy today: Caplin Point Laboratories (2,205) BUY
    Business Line | 22 Aug 2025
    logo
    Granules India Ltd.
    22 Aug 2025
    511.40
    -0.28%
    Can Granules India leverage its strong product pipeline to offset recent profit declines?
    Can Granules India leverage its strong product pipeline to offset recent profit declines?
    Economic Times
    Granules India's stock shows a slight recovery despite reporting lower profits in the June quarter. Investors are positive about the company's product pipeline and business stabilisation. The company anticipates better growth in FY27. Approvals for six products in Europe are awaited. Granules focuses on CNS, ADHD, and oncology products. The Gagillapur facility remediation is progressing well with US FDA.
    Copy LinkShare onShare on Share on Share on
    Granules India Ltd. has lost -27.34% in the last 1 Year
    logo
    Concord Biotech Ltd.
    21 Aug 2025
    1657.70
    -0.66%
    Concord Biotech shares jump 6 per cent; here's what is fueling the gains
    Business Standard
    The upward movement in the pharmaceutical company's stock price followed an announcement regarding the company's Limbasi API facility
    Copy LinkShare onShare on Share on Share on
    Concord Biotech Ltd. is trading below all available SMAs
    more
    loading
    Logo Trendlyne

    Stay ahead of the market

    Company

    PrivacyDisclaimerTerms of Use Contact Us

    Resources

    Blog FAQsStock Market Widgets

    Copyright © 2025 Giskard Datatech Pvt Ltd